| 1 | (7R,8R,9R)-2.3-Dimethyl-8-hydroxy-7(2-methoxyethoxy)- 9-phenyl-7.8.9.10-tetrahydro-imidazo-[1.2-h].[1.7].- naphthyridine | - | - | - | - | 1件: 301 301 💬
|
| 2 | 4-Methylpyrazole | - | - | - | - | 1件: 301 301 💬
|
| 3 | [ACU-4429] | - | - | - | - | 1件: 301 301 💬
|
| 4 | [ARC1905] | - | - | - | - | 1件: 301 301 💬
|
| 5 | [EU/3/13/1208 orphan] | - | - | - | - | 1件: 301 301 💬
|
| 6 | AAVB-039 | - | - | - | - | 1件: 301 301 💬
|
| 7 | ACDN-01 | - | - | - | - | 2件: 90 90, 301 💬
|
| 8 | ACU-4429 | - | - | - | - | 1件: 301 301 💬
|
| 9 | ALK-001 | - | - | - | - | 1件: 301 301 💬
|
| 10 | ALK-001 (No generic name) | - | - | - | - | 1件: 301 301 💬
|
| 11 | ARC1905 | - | - | - | - | 1件: 301 301 💬
|
| 12 | ARC1905 20 MG/ML | - | - | - | - | 1件: 301 301 💬
|
| 13 | Avacincaptad pegol | 1件: Avacincaptad pegol Avacincaptad pegol | 1件: Avacincaptad pegol sodium
Avacincaptad pegol sodium
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 301 301 💬
|
| 14 | DC6001 | - | - | - | - | 1件: 301 301 💬
|
| 15 | Diagnostic Test: Ocular Coherence Tomography-Angiography (OCT-A) | - | - | - | - | 2件: 90 90, 301 💬
|
| 16 | Disulfiram | 1件: Disulfiram Disulfiram | 1件: Disulfiram
Disulfiram
💬
| 3件: ALDH1B1 ALDH1B1, ALDH2, ALDH3A2 💬
| 13件: Alcoholic liver disease Alcoholic liver disease, Arginine and proline metabolism, Ascorbate and aldarate metabolism, Fatty acid degradation, Glycerolipid metabolism, Glycolysis / Gluconeogenesis, Histidine metabolism, Lysine degradation, Pantothenate and CoA biosynthesis, Pyruvate metabolism, Tryptophan metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | 3件: 46 46, 90, 301 💬
|
| 17 | Docosahexaenoic Acid (DHA) Dietary Supplement | - | - | - | - | 2件: 13 13, 301 💬
|
| 18 | Emixustat | 1件: Emixustat Emixustat | 1件: Emixustat
Emixustat
💬
| - | - | 1件: 301 301 💬
|
| 19 | Emixustat hydrochloride | 1件: Emixustat Emixustat | 1件: Emixustat
Emixustat
💬
| - | - | 1件: 301 301 💬
|
| 20 | EMIXUSTAT HYDROCHLORIDE (ACU-4429) | 1件: Emixustat Emixustat | 1件: Emixustat
Emixustat
💬
| - | - | 1件: 301 301 💬
|
| 21 | Gene Therapy Product-MCO-010 | - | - | - | - | 2件: 90 90, 301 💬
|
| 22 | Gene Therapy-vMCO-010 | - | - | - | - | 1件: 301 301 💬
|
| 23 | Genetic: Blood and/or skin biopsy | - | - | - | - | 2件: 90 90, 301 💬
|
| 24 | Genetic: HG005 | - | - | - | - | 1件: 301 301 💬
|
| 25 | Genetic: JWK006 | - | - | - | - | 1件: 301 301 💬
|
| 26 | Genetic: OPGx-BEST1 | - | - | - | - | 1件: 301 301 💬
|
| 27 | Genetic: RTx-021 | - | - | - | - | 1件: 301 301 💬
|
| 28 | Genetic: SB-007 | - | - | - | - | 1件: 301 301 💬
|
| 29 | HESC-RPE | - | - | - | - | 1件: 301 301 💬
|
| 30 | Injection | - | - | - | - | 2件: 6 6, 301 💬
|
| 31 | Interferon Gamma | 1件: Interferon Gamma Interferon Gamma | - | - | - | 9件: 18 18, 65, 85, 96, 107, 228, 299, 301, 326 💬
|
| 32 | INTERFERON GAMMA-1B | 2件: Interferon Gamma Interferon Gamma, Interferon gamma-1b | 1件: Interferon gamma-1b
Interferon gamma-1b
💬
| 2件: IFNGR1 IFNGR1, IFNGR2 💬
| 18件: Chagas disease Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬 | 7件: 18 18, 65, 85, 228, 299, 301, 326 💬
|
| 33 | LBS-008, BPN-14967 | - | - | - | - | 1件: 301 301 💬
|
| 34 | Lentiviral vector containing ABCA4 gene | - | - | - | - | 1件: 301 301 💬
|
| 35 | Lentiviral vector containing the ABCA4 gene | - | - | - | - | 1件: 301 301 💬
|
| 36 | Long term follow up in all patients who received SAR422459 in previous study TDU13583 | 1件: SAR422459 SAR422459 | - | - | - | 1件: 301 301 💬
|
| 37 | MA09-hRPE | - | - | - | - | 1件: 301 301 💬
|
| 38 | Madeos | - | - | - | - | 1件: 301 301 💬
|
| 39 | Mesenchymal Stem Cell-Derived Exosomes | 1件: Mesenchymal Stem Cell-Derived Exosomes Mesenchymal Stem Cell-Derived Exosomes | - | - | - | 2件: 127 127, 301 💬
|
| 40 | Metformin | 1件: Metformin Metformin | 2件: Metformin hydrochloride
Metformin hydrochloride
,
Metformin
💬
| 2件: PRKAA1 PRKAA1, PRKAA2 💬
| 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 31件: 2 2, 6, 8, 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
|
| 41 | METFORMIN HYDROCHLORIDE | 1件: Metformin Metformin | 2件: Metformin hydrochloride
Metformin hydrochloride
,
Metformin
💬
| 2件: PRKAA1 PRKAA1, PRKAA2 💬
| 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 5件: 81 81, 158, 265, 299, 301 💬
|
| 42 | OCU410ST | 1件: OCU410ST OCU410ST | - | - | - | 1件: 301 301 💬
|
| 43 | OpCT-001 | - | - | - | - | 3件: 90 90, 301, 303 💬
|
| 44 | Oral disulfiram | 1件: Disulfiram Disulfiram | 1件: Disulfiram
Disulfiram
💬
| 3件: ALDH1B1 ALDH1B1, ALDH2, ALDH3A2 💬
| 13件: Alcoholic liver disease Alcoholic liver disease, Arginine and proline metabolism, Ascorbate and aldarate metabolism, Fatty acid degradation, Glycerolipid metabolism, Glycolysis / Gluconeogenesis, Histidine metabolism, Lysine degradation, Pantothenate and CoA biosynthesis, Pyruvate metabolism, Tryptophan metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | 2件: 90 90, 301 💬
|
| 45 | Other: Saline | - | - | - | - | 8件: 2 2, 6, 46, 97, 98, 256, 274, 301 💬
|
| 46 | Other: Standard of Care Sildenafil | 1件: Sildenafil Sildenafil | 2件: Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| 1件: PDE5A PDE5A 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 2件: 90 90, 301 💬
|
| 47 | Other: Visual Acuity (VA) | - | - | - | - | 2件: 90 90, 301 💬
|
| 48 | Over the counter DHA/EPA dietary supplementation | - | - | - | - | 1件: 301 301 💬
|
| 49 | Ranibizumab | 1件: Ranibizumab Ranibizumab | 1件: Ranibizumab
Ranibizumab
💬
| 1件: VEGFA VEGFA 💬
| 24件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Integrin signaling, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | 4件: 34 34, 166, 227, 301 💬
|
| 50 | Ranibizumab injection (0.5 mg) | 1件: Ranibizumab Ranibizumab | 1件: Ranibizumab
Ranibizumab
💬
| 1件: VEGFA VEGFA 💬
| 24件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Integrin signaling, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | 2件: 166 166, 301 💬
|
| 51 | Saffron supplementation | - | - | - | - | 1件: 301 301 💬
|
| 52 | SAR422459 | 1件: SAR422459 SAR422459 | - | - | - | 1件: 301 301 💬
|
| 53 | Sham | - | - | - | - | 4件: 90 90, 211, 301, 303 💬
|
| 54 | Sildenafil | 1件: Sildenafil Sildenafil | 2件: Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| 1件: PDE5A PDE5A 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 17件: 6 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
|
| 55 | SORAPRAZAN | 1件: Soraprazan Soraprazan | - | - | - | 1件: 301 301 💬
|
| 56 | SPVN06 | - | - | - | - | 2件: 90 90, 301 💬
|
| 57 | StarGen | - | - | - | - | 1件: 301 301 💬
|
| 58 | Stem/progenitor cells transplantation | - | - | - | - | 2件: 90 90, 301 💬
|
| 59 | STG-001 | 1件: STG-001 STG-001 | - | - | - | 1件: 301 301 💬
|
| 60 | Tinlarebant | 1件: Tinlarebant Tinlarebant | 1件: Tinlarebant
Tinlarebant
💬
| - | - | 1件: 301 301 💬
|
| 61 | TinlarebantProduct Code: LBS-008, BPN-14967Pharmaceutical Form: TabletINN or Proposed INN: TinlarebantCAS Number: NACurrent Sponsor code: LBS-008, BPN-14967Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 5-Pharmaceutical form of the placebo: TabletRoute of administration of the placebo: Oral use | - | - | - | - | 1件: 301 301 💬
|
| 62 | TOBRAMYCIN | 1件: Tobramycin Tobramycin | 2件: Tobramycin
Tobramycin
,
Tobramycin sulfate
💬
| - | - | 2件: 299 299, 301 💬
|
| 63 | Vett Lentiviral con gene ABCA4 | - | - | - | - | 1件: 301 301 💬
|
| 64 | VG801 | - | - | - | - | 1件: 301 301 💬
|
| 65 | Zimura | - | - | - | - | 1件: 301 301 💬
|